| Name | Exchange | Split Ratio |
|---|---|---|
BDRX Biodexa Pharmaceuticals PLC ADR 31 Jul 2025 | NASDAQ (CM) | 1:10 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 4 Oct 2024 | NASDAQ (CM) | 1:25 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 5 Jul 2023 | NASDAQ (CM) | 1:80 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 27 Mar 2023 | NASDAQ (CM) | 1:4 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 26 Sep 2022 | NASDAQ (CM) | 1:5 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 3 Mar 2020 | NASDAQ (CM) | 1:5 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 8 Apr 2019 | NASDAQ (CM) | 1:10 Split Ratio |
BDRX Biodexa Pharmaceuticals PLC ADR 29 Sep 2017 | NASDAQ (CM) | 815:803 Split Ratio |